{"id":61261,"date":"2024-02-28T07:32:49","date_gmt":"2024-02-28T07:32:49","guid":{"rendered":"https:\/\/medsname.com\/vilano\/"},"modified":"2026-05-01T10:49:16","modified_gmt":"2026-05-01T10:49:16","slug":"vilano","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/vilano\/","title":{"rendered":"Vilano"},"content":{"rendered":"

<\/p>\n

\n

⚡ Quick Answer — What is Vilano?<\/h3>\n
\n

Vilano<\/strong> obsahuje vilazodone 40 mg<\/strong> from a WHO-GMP certified manufacturer (Lupin Pharmaceuticals) — a dual-mechanism antidepressant<\/strong>: SERT inhibition (SSRI) plus<\/em> 5-HT1A<\/sub> partial agonism. FDA-approved 2011 for MDD only<\/strong> (no anxiety or other indications). Standard target dose: 40 mg once daily with food<\/strong> (must be taken with at least 500 calories — bioavailability halves on an empty stomach). Titrate from 10 mg over 2 weeks to reduce GI side effects. Sexual side-effect rate is lower than other SSRIs<\/strong> — the 5-HT1A<\/sub> partial agonism is the proposed reason. Diarrhoea is the most common bothersome side effect. Onset 2–4 weeks; full response by 8 weeks.<\/p>\n<\/div>\n

\nCo z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdrobce certifikovan\u00fd WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 doprava \u00b7 V\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdch recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a>\n<\/div>\n

\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n

Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n

Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n<\/div>\n

Important — this is not a situational-anxiety medication.<\/strong> Vilano is a SSRI plus 5-HT1A partial agonist<\/strong>, prescribed and titrated over weeks for major depressive disorder (MDD)<\/strong>. It is ne<\/strong> the right drug for acute, performance-related anxiety (flying, public speaking, exams) — for those use cases beta-blockers (propranolol), benzodiazepines, or hydroxyzine are clinically appropriate. If you do not have a diagnosed mood, anxiety, or psychiatric disorder, do not start this medication.<\/div>\n
FDA black-box warning — suicidality.<\/strong> All antidepressants carry an FDA black-box warning for increased risk of suicidal thinking and behaviour in children, adolescents, and young adults under 25, particularly during the first weeks of treatment or after dose changes. Family members and prescribers should monitor closely for worsening mood, agitation, or suicidal ideation in this age group.<\/div>\n

What Is Vilano?<\/h2>\n

Vilano is an oral tablet of vilazodone hydrochloride 40 mg<\/strong> manufactured by Lupin Pharmaceuticals. Vilazodone (US brand Viibryd<\/strong>) was FDA-approved in 2011 as a dual-mechanism antidepressant: it combines selective serotonin reuptake inhibition (SSRI) with 5-HT1A<\/sub> partial agonism<\/strong>, similar to the partial agonism of buspirone. The 5-HT1A<\/sub> partial agonism is proposed to reduce the sexual side-effect burden seen with classical SSRIs.<\/p>\n

Schv\u00e1len\u00e9 indikace<\/h2>\n